NanoViricides, Inc. Has Posted Dr. Seymour’s CEO Letter on the Company Website - Dr. Seymour to Present Today at the Roth C...
March 12 2014 - 7:00AM
Business Wire
NanoViricides, Inc. (NYSE MKT:NNVC) (the “Company”) has posted
the Company’s CEO Dr. Seymour’s “Letter to Shareholders” on its
website (www.nanoviricides.com) yesterday. Dr. Seymour has provided
a calendar year end overview of the Company for the benefit of the
shareholders in this letter. In response to inquiries Dr. Seymour
has received from several shareholders, this letter also discusses
the strong performance of NanoViricides, Inc. since it was founded
in 2005, the Company’s continued progress in developing its
platform technology, its rich and wide pipeline of industry-leading
broad-spectrum antiviral drug candidates, the global intellectual
property leadership, the Company’s strong corporate governance, the
Company’s frugal business strategy that has helped the Company
produce a strong and wide drug pipeline at a very low cost of
development compared to the industry, and select highlights of what
the Company expects to achieve in calendar year 2014 and the near
future.
In addition, the Company announces that Dr. Seymour will present
an overview of the Company today at the annual Roth Capital
Conference that is currently underway at the Ritz-Carlton Hotel in
Laguna Niguel, California. This is the second year that Dr. Seymour
has been asked to present at this invitation-only conference.
About NanoViricides:
NanoViricides, Inc. (www.nanoviricides.com) is a development stage
company that is creating special purpose nanomaterials for viral
therapy. The Company's novel nanoviricide® class of drug candidates
are designed to specifically attack enveloped virus particles and
to dismantle them. The Company is developing drugs against a number
of viral diseases including H1N1 swine flu, H5N1 bird flu, seasonal
Influenza, HIV, oral and genital Herpes, viral diseases of the eye
including EKC and herpes keratitis, Hepatitis C, Rabies, Dengue
fever, and Ebola virus, among others.
This press release contains forward-looking statements that
reflect the Company's current expectation regarding future events.
Actual events could differ materially and substantially from those
projected herein and depend on a number of factors. Certain
statements in this release, and other written or oral statements
made by NanoViricides, Inc. are “forward-looking statements” within
the meaning of Section 27A of the Securities Act of 1933 and
Section 21E of the Securities Exchange Act of 1934. You should not
place undue reliance on forward-looking statements since they
involve known and unknown risks, uncertainties and other factors
which are, in some cases, beyond the Company's control and which
could, and likely will, materially affect actual results, levels of
activity, performance or achievements. The Company assumes no
obligation to publicly update or revise these forward-looking
statements for any reason, or to update the reasons actual results
could differ materially from those anticipated in these
forward-looking statements, even if new information becomes
available in the future. Important factors that could cause actual
results to differ materially from the company's expectations
include, but are not limited to, those factors that are disclosed
under the heading "Risk Factors" and elsewhere in documents filed
by the company from time to time with the United States Securities
and Exchange Commission and other regulatory authorities. Although
it is not possible to predict or identify all such factors, they
may include the following: demonstration and proof of principle in
pre-clinical trials that a nanoviricide is safe and effective;
successful development of our product candidates; our ability to
seek and obtain regulatory approvals, including with respect to the
indications we are seeking; the successful commercialization of our
product candidates; and market acceptance of our products.
NanoViricides, Inc.Amanda Schuon,
310-550-7200info@nanoviricides.com
NanoViricides (AMEX:NNVC)
Historical Stock Chart
From Aug 2024 to Sep 2024
NanoViricides (AMEX:NNVC)
Historical Stock Chart
From Sep 2023 to Sep 2024